Search
Filters
total: 69
filtered: 60
-
Catalog
Chosen catalog filters
Search results for: PSORIASIS
-
Psoriasis and cardiometabolic disorders
Publication -
Sleep disorders in psoriasis
Publication -
The role of lipids in psoriasis
Publication -
Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
PublicationPsoriasis is a systemic disease that is strictly connected with metabolic disorders (insulin resistance, atherogenic dyslipidemia, arterial hypertension, and cardiovascular diseases). It occurs more often in patients with a more severe course of the disease. Obesity is specially an independent risk factor and it is associated with a worse treatment outcome because of the high inflammatory activity of visceral fatty tissue and...
-
Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis
PublicationPsoriasis is a multifactorial disease in which genetic, environmental and epigenetic factors regulating gene expression play a key role. In the “genomic era”, genome-wide association studies together with target genotyping platforms performed in different ethnic populations have found more than 50 genetic susceptible markers associated with the risk of psoriasis which have been identified so far. Up till now, the strongest association...
-
Selected aspects of apoptosis in psoriasis
Publication -
Models in the Research Process of Psoriasis
Publication -
Aberrations in Lipid Expression and Metabolism in Psoriasis
Publication -
Serum irisin levels in patients with psoriasis
Publication -
Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis
Publication -
Factors affecting response to biologic treatment in psoriasis
Publication -
Serum fatty acid profile in psoriasis and its comorbidity
Publication -
Serum YKL-40 as a potential biomarker of inflammation in psoriasis
Publication -
Effect of psoriasis activity on serum adiponectin and leptin levels
Publication -
Role of omentin and vaspin in metabolic diseases in association with psoriasis
Publication -
Unbalanced Sphingolipid Metabolism and Its Implications for the Pathogenesis of Psoriasis
Publication -
Impact of isoflavone genistein on psoriasis in in vivo and in vitro investigations
Publication -
Epidemiological evaluation of paediatric psoriasis patients at the Dermatology Department
Publication -
Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability
Publication -
Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects
PublicationSkin diseases such as psoriasis (Ps) and psoriatic arthritis (PsA) are immune-mediated inflammatory diseases. Overlap of autoinflammatory and autoimmune conditions hinders diagnoses and identifying personalized patient treatments due to different psoriasis subtypes and the lack of verified biomarkers. Recently, proteomics and metabolomics have been intensively investigated in a broad range of skin diseases with the main purpose...
-
Significance of selected inflammatory factors in metabolic disorders in association with psoriasis
Publication -
Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis
Publication -
Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels
Publication -
Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis
Publication -
Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis
Publication -
Mutual Relationship Between Sleep Disorders, Quality of Life and Psychosocial Aspects in Patients With Psoriasis
Publication -
Adipocyte Fatty Acid‐Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin
Publication -
The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels
Publication -
ERAP1 and HLA-C*06 are strongly associated with the risk of psoriasis in the population of northern Poland
Publication -
Lysosome Alterations in the Human Epithelial Cell Line HaCaT and Skin Specimens: Relevance to Psoriasis
Publication -
Psoriasis and Atherosclerosis—Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics
Publication -
Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases
Publication -
Upregulation of the sFas/sFasL system in psoriatic patients
Publication -
Genistein modulates gene activity in psoriatic patients
Publication -
Decreased levels of 6-tetrahydrobiopterin in psoriatic epidermis
Publication -
The Assessment of Risk and Predictors of Sleep Disorders in Patients with Psoriasis—A Questionnaire-Based Cross-Sectional Analysis
Publication -
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
Publication -
Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances
Publication -
A crossroads between dietary habits, alcohol consumption, and smoking in the clinical course of psoriasis: a narrative review
Publication -
Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
Publication -
Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK)
Publication -
Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data
Publication -
Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis
Publication -
Assessment of Interleukin 16 Serum Levels and Skin Expression in Psoriasis Patients in Correlation with Clinical Severity of the Disease
Publication -
Galectin-3 as a Novel Multifaceted and Not Only Cardiovascular Biomarker in Patients with Psoriasis with Regard to Systemic Treatment—Preliminary Data
Publication -
Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR)
Publication -
Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales
Publication -
Hula-hooping as an unusual cause of Koebner phenomenon in a psoriatic patient
Publication -
Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data
Publication -
Evaluation of CD40, its ligand CD40L and Bcl-2 in psoriatic patients
Publication